Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 40 of the 43 references it cites were found in a registry or an index.

Effects of Vascular-Endothelial Protein Tyrosine Phosphatase Inhibition on Breast Cancer Vasculature and Metastatic Progression

Open access

Abstract

BACKGROUND: The solid tumor microvasculature is characterized by structural and functional abnormality and mediates several deleterious aspects of tumor behavior. Here we determine the role of vascular endothelial protein tyrosine phosphatase (VE-PTP), which deactivates endothelial cell (EC) Tie-2 receptor tyrosine kinase, thereby impairing maturation of tumor vessels. METHODS: AKB-9778 is a first-in-class VE-PTP inhibitor. We examined its effects on ECs in vitro and on embryonic angiogenesis in vivo using zebrafish assays. We studied the impact of AKB-9778 therapy on the tumor vasculature, tumor growth, and metastatic progression using orthotopic models of murine mammary carcinoma as well as spontaneous and experimental metastasis models. Finally, we used endothelial nitric oxide synthase (eNOS)-deficient mice to establish the role of eNOS in mediating the effects of VE-PTP inhibition. All statistical tests were two-sided. RESULTS: AKB-9778 induced ligand-independent Tie-2 activation in ECs and impaired embryonic zebrafish angiogenesis. AKB-9778 delayed the early phase of mammary tumor growth by maintaining vascular maturity (P < .01, t test); slowed growth of micrometastases (P < .01, χ(2) test) by preventing extravasation of tumor cells (P < 0.01, Fisher exact test), resulting in a trend toward prolonged survival (27.0 vs 36.5 days; hazard ratio of death = 0.33, 95% confidence interval = 0.11 to 1.03; P = .05, Mantel-Cox test); and stabilized established primary tumor blood vessels, enhancing tumor perfusion (P = .03 for 4T1 tumor model and 0.05 for E0771 tumor model, by two-sided t tests) and, hence, radiation response (P < .01, analysis of variance; n = 7 mice per group). The effects of AKB-9778 on tumor vessels were mediated in part by endothelial nitric oxide synthase activation. CONCLUSIONS: Our results demonstrate that pharmacological VE-PTP inhibition can normalize the structure and function of tumor vessels through Tie-2 activation, which delays tumor growth, slows metastatic progression, and enhances response to concomitant cytotoxic treatments.

Overview

Integrity signals

Registry

Crossref · 10.1093/jnci/djt164

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Research works printed but not linked: 1

  1. Aerpio, Aerpio announces positive phase 1 data on first-in-class Tie-2 activator, AKB-9778, in development for diabetic macular edema, 2012

Cited by

See all 127

Metadata

Authors
Goel, S., Gupta, N., Walcott, B. P., Snuderl, M., Kesler, C. T., Kirkpatrick, N. D., Heishi, T., Huang, Y., Martin, J. D., Ager, E., Samuel, R., Wang, S., Yazbek, J., Vakoc, B. J., Peterson, R. T., Padera, T. P., Duda, D. G., Fukumura, D., & Jain, R. K.
Affiliations
Harvard University (US)
Venue
JNCI: Journal of the National Cancer Institute
Published
2013-08-13
Volume
105
Issue
16
Pages
1188-1201
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2005508881
Cited by
117
References
43
Citations by year
2026: 2 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 9 · 2019: 13 · 2018: 7 · 2017: 13 · 2016: 14 · 2015: 5 · 2014: 10 · 2013: 3
FWCI
4.77
Type
journal article
Language
en
Open access
Locations
  • JNCI Journal of the National Cancer Institute (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institutes of Health (1s10rr027070-01, 1dp2od008780-01)
  • National Cancer Institute (T32CA073479, R01CA159258, R01CA096915, P01CA080124, R00CA137167, R01CA126642, R01CA163528, K12CA090354)
  • National Institute of Biomedical Imaging and Bioengineering (P41EB015903)
  • National Center for Research Resources (S10-RR027070)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
tumor vasculature, breast cancer metastasis, tumor cell extravasation, endothelial nitric oxide synthase, tumor perfusion, radiation response, embryonic angiogenesis, zebrafish
MeSH terms
Animals, Antineoplastic Agents, Breast Neoplasms, Drug Synergism, Enzyme Activation, Enzyme Inhibitors, Female, Lung Neoplasms, Mice, Inbred C57BL, Neovascularization, Pathologic, Zebrafish, Disease Progression, Angiogenesis Inhibitors, Xenograft Model Antitumor Assays, Zebrafish Proteins, Receptor, TIE-2, Mice, Nitric Oxide Synthase Type III, Receptor-Like Protein Tyrosine Phosphatases, Class 3, Human Umbilical Vein Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Vascular-Endothelial Protein Tyrosine Phosphatase Inhibition on Breast Cancer Vasculature and Metastatic Progression. https://app.cochat.ai/papers/10.1093/jnci/djt164
The paper
Goel, S., Gupta, N., Walcott, B. P., Snuderl, M., Kesler, C. T., Kirkpatrick, N. D., Heishi, T., Huang, Y., Martin, J. D., Ager, E., Samuel, R., Wang, S., Yazbek, J., Vakoc, B. J., Peterson, R. T., Padera, T. P., Duda, D. G., Fukumura, D., & Jain, R. K. (2013). Effects of Vascular-Endothelial Protein Tyrosine Phosphatase Inhibition on Breast Cancer Vasculature and Metastatic Progression. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djt164

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.